Abstract

Epilepsy is a chronic and debilitating neurological disorder, with a worldwide prevalence of 0.5–1% and a lifetime incidence of 1–3%. An estimated 30% of epileptic patients continue to experience seizures throughout life, despite adequate drug therapy or surgery, with a major impact on society and global health. In recent decades, dietary regimens have been used effectively in the treatment of drug-resistant epilepsy, following the path of a non-pharmacological approach. The ketogenic diet and its variants (e.g., the modified Atkins diet) have an established role in contrasting epileptogenesis through the production of a series of cascading events induced by physiological ketosis. Other dietary regimens, such as caloric restriction and a gluten free diet, can also exert beneficial effects on neuroprotection and, therefore, on refractory epilepsy. The purpose of this review was to analyze the evidence from the literature about the possible efficacy of different dietary regimens on epilepsy, focusing on the underlying pathophysiological mechanisms, safety, and tolerability both in pediatric and adult population. We believe that a better knowledge of the cellular and molecular biochemical processes behind the anticonvulsant effects of alimentary therapies may lead to the development of personalized dietary intervention protocols.

Highlights

  • Epilepsy is one of the most common neurological diseases, with a worldwide prevalence of0.5–1% and a lifetime incidence of 1–3% [1]

  • This chronic condition is often controlled through a pharmacological approach; 30% of affected patients develop a drug–resistant epilepsy (DRE), which is defined after the “failure of adequate trials of two tolerated and appropriately chosen and used antiepileptic drugs schedules to achieve sustained seizure freedom” [2]

  • We reviewed clinical efficacy of ketogenic diet (KD) in children and adult epilepsy, safety, and tolerability, in addition to provide special consideration when treating different age populations

Read more

Summary

Introduction

Epilepsy is one of the most common neurological diseases, with a worldwide prevalence of. The classic ketogenic diet (KD) has long been used in the treatment of refractory epilepsy in children and adults or in patients not candidates for surgery, showing evidence of efficacy especially in the pediatric population, KD remains a valid therapeutic choice [4,5]. Atkins diet (MAD), the low-glycemic index treatment (LGIT), and the medium-chain triglyceride diet (MCTD) for the treatment of epilepsy and other neurological diseases [6]. We reviewed clinical efficacy of KD in children and adult epilepsy, safety, and tolerability, in addition to provide special consideration when treating different age populations. Abbreviation: MAD, modified Atkins diet; LGIT, low-glycemic index treatment; MCTD, medium-chain triglyceride diet. References: [7,8,9]

Different Dietary Regimens Inducing Ketosis
Responders and Non-Responders to the Ketogenic Diet
Pathophysiology of Ketogenic Diet and Epilepsy
Clinical Efficacy against Epilepsy
Participants
Refractory Epilepsy
Other Childhood Epilepsies
Adult Population
Tolerability
General Comment
Short Term Adverse Events
Long Term Adverse Events
Exclusion Criteria of the Ketogenic Diet
Variation of Ketogenic Diet Regimen per Age Group
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call